236 related articles for article (PubMed ID: 21749676)
1. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.
Hasslacher J; Bijuklic K; Bertocchi C; Kountchev J; Bellmann R; Dunzendorfer S; Joannidis M
Crit Care; 2011 Jul; 15(4):R166. PubMed ID: 21749676
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting.
Yilmaz MB; Mebazaa A
Crit Care; 2011 Aug; 15(4):182. PubMed ID: 21892973
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure.
Adam M; Meyer S; Knors H; Klinke A; Radunski UK; Rudolph TK; Rudolph V; Spin JM; Tsao PS; Costard-Jäckle A; Baldus S
Sci Rep; 2015 Apr; 5():9704. PubMed ID: 25867530
[TBL] [Abstract][Full Text] [Related]
4. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
5. Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock.
Oldner A; Konrad D; Weitzberg E; Rudehill A; Rossi P; Wanecek M
Crit Care Med; 2001 Nov; 29(11):2185-93. PubMed ID: 11700420
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
Antila S; Eha J; Heinpalu M; Lehtonen L; Loogna I; Mesikepp A; Planken U; Sandell EP
Eur J Clin Pharmacol; 1996; 49(6):451-8. PubMed ID: 8706769
[TBL] [Abstract][Full Text] [Related]
7. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
Xu CX; Li L; Gong SJ; Yu YH; Yan J
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):423-428. PubMed ID: 29925127
[No Abstract] [Full Text] [Related]
8. Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolated septic rat hearts.
Zausig YA; Geilfus D; Missler G; Sinner B; Graf BM; Zink W
Shock; 2010 Sep; 34(3):269-74. PubMed ID: 19997056
[TBL] [Abstract][Full Text] [Related]
9. Modulation of immune functions in polymorphonuclear neutrophils induced by physostigmine, but not neostigmine, independent of cholinergic neurons.
Bitzinger DI; Zausig YA; Paech C; Gruber M; Busse H; Sinner B; Graf BM; Trabold B
Immunobiology; 2013 Aug; 218(8):1049-54. PubMed ID: 23434434
[TBL] [Abstract][Full Text] [Related]
10. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
Duygu H; Nalbantgil S; Ozerkan F; Zoghi M; Akilli A; Erturk U; Akin M; Nazli C; Ergene O
Clin Cardiol; 2008 Dec; 31(12):607-13. PubMed ID: 19072879
[TBL] [Abstract][Full Text] [Related]
12. Renal effects of levosimendan: a consensus report.
Yilmaz MB; Grossini E; Silva Cardoso JC; Édes I; Fedele F; Pollesello P; Kivikko M; Harjola VP; Hasslacher J; Mebazaa A; Morelli A; le Noble J; Oldner A; Oulego Erroz I; Parissis JT; Parkhomenko A; Poelzl G; Rehberg S; Ricksten SE; Rodríguez Fernández LM; Salmenperä M; Singer M; Treskatsch S; Vrtovec B; Wikström G
Cardiovasc Drugs Ther; 2013 Dec; 27(6):581-90. PubMed ID: 23929366
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
Yontar OC; Yilmaz MB; Yalta K; Erdem A; Tandogan I
Arq Bras Cardiol; 2010 Dec; 95(6):738-42. PubMed ID: 21109913
[TBL] [Abstract][Full Text] [Related]
14. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
[TBL] [Abstract][Full Text] [Related]
15. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
Bragadottir G; Redfors B; Ricksten SE
Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro.
Krychtiuk KA; Watzke L; Kaun C; Buchberger E; Hofer-Warbinek R; Demyanets S; Pisoni J; Kastl SP; Rauscher S; Gröger M; Aliabadi A; Zuckermann A; Maurer G; de Martin R; Huber K; Wojta J; Speidl WS
Thromb Haemost; 2015 Feb; 113(2):350-62. PubMed ID: 25273157
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
Lehtonen L
Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
Kivikko M; Lehtonen L
Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Biala A; Martonen E; Kaheinen P; Levijoki J; Finckenberg P; Merasto S; Louhelainen M; Muller DN; Luft FC; Mervaala E
Hypertens Res; 2010 Oct; 33(10):1004-11. PubMed ID: 20811386
[TBL] [Abstract][Full Text] [Related]
20. [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock].
Fang M; Dong S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):692-6. PubMed ID: 25315937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
